Month: <span>June 2021</span>

Home / 2021 / June
Drug doubles down on bone cancer and metastasis
Post

Drug doubles down on bone cancer and metastasis

by Mike Williams,  Rice University Scientists at Rice University and Baylor College of Medicine are using pClick conjugation to create therapeutic antibodies that target bone cancers. The conjugate incorporates bisphosphonate molecules that bind to the bone hydroxyapatite matrix. Credit: Baylor College of Medicine/Rice University Bone cancer is hard to treat and prone to metastasis. Research teams...

Western high-fat diet can cause chronic pain, according to research team
Post

Western high-fat diet can cause chronic pain, according to research team

by  University of Texas Health Science Center at San Antonio Credit: CC0 Public Domain A typical Western high-fat diet can increase the risk of painful disorders common in people with conditions such as diabetes or obesity, according to a groundbreaking paper authored by a team led by The University of Texas Health Science Center at San...

Post

It’s true: Stress does turn hair gray (and it’s reversible)

COLUMBIA UNIVERSITY IRVING MEDICAL CENTER Legend has it that Marie Antoinette’s hair turned gray overnight just before her beheading in 1791. Though the legend is inaccurate–hair that has already grown out of the follicle does not change color–a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons is the first to offer quantitative...

Post

Review shows minimal, high-quality evidence dietary supplements lead to weight loss

THE OBESITY SOCIETY  SILVER SPRING, Md.– Although Americans spend billions on them, published research shows a lack of strong evidence that dietary supplements and alternative therapies help adults lose weight, according to a new study published in Obesity, the flagship journal of The Obesity Society (TOS). There are hundreds of weight-loss supplements like green tea extract, chitosan, guar...

Post

Antibody therapy rescues mice from lethal nerve-muscle disease

NYU LANGONE HEALTH / NYU GROSSMAN SCHOOL OF MEDICINE Researchers rescued mice from early death caused by a muscle-weakening disease, not by correcting the flawed gene that causes it, but instead by targeting another protein in the same signaling pathway.  Led by NYU Grossman School of Medicine researchers, a new study found that an antibody treatment not...

Post

Can genetic tests predict children’s risk of developing scoliosis?

WILEY In a study published in the Journal of Bone and Mineral Research, investigators developed and validated a genetic risk score for predicting the onset and severity of the most common type of scoliosis in adolescents–called adolescent idiopathic scoliosis (AIS). AIS causes spinal deformities in as many as 3% of youth, and because its heritability is high,...

Scientists uncover new mechanism that enables development of cancer
Post

Scientists uncover new mechanism that enables development of cancer

UNC LINEBERGER COMPREHENSIVE CANCER CENTER IMAGE: “Because similar gene fusions have been observed in other malignancies, the mechanism we elucidated could explain other types of cancer as well,” said UNC Lineberger’s Douglas H. Phanstiel, Ph.D. “We believe that our research could open up new and innovative avenues to attack cancer cells.” CREDIT: UNIVERSITY OF NORTH...

Rap1 controls the body’s sugar levels from the brain
Post

Rap1 controls the body’s sugar levels from the brain

by  Baylor College of Medicine Modifying the activity of gene Rap1 in VMH neurons of the hypothalamus can regulate blood glucose in an animal model. Credit: M. Fukuda/JCI insight, 2021 Managing type 2 diabetes typically involves losing weight, exercise, and medication, but new research by Dr. Makoto Fukuda and colleagues at Baylor College of Medicine and...

SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model
Post

SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model

by  Medical University of South Carolina Hollings Cancer Center researcher Nancy Klauber-DeMore, M.D., is leading the first breakthrough in pediatric osteosarcoma treatment in decades. Credit: MUSC Hollings Cancer Center/Marquel Coaxum In cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist Nancy Klauber-DeMore, M.D., is pioneering new...